HomeHomeHome
Home
CCHD - Critical congenital heart disease - Condition Details

Critical congenital heart disease (CCHD) is a category of congenital heart disease that includes a range of disorders requiring intervention soon after birth. Screening consists of measuring the oxygen saturation (as a reflection of hypoxemia) by using a pulse oximeter in the right hand as well as either foot. Babies who screen positive do not necessarily have CCHD, as other conditions can also lead to low oxygen saturation. Diagnostic testing for CCHD includes echocardiogram and cardiac catheterization. Primary treatment is usually surgical. CCHD includes the following conditions: hypoplastic left heart syndrome, pulmonary atresia, truncus arteriosus, total anomalous pulmonary venous connection, d-transposition of the great arteries, tetralogy of Fallot, and tricuspid atresia.

Names and Codes

Condition:1 Critical congenital heart disease
Abbreviation:1 CCHD
Category:2 Core
SNOMED CT Code:3
61959006Common arterial trunk (truncus arteriosus)
26146002Complete transposition of great vessels
204342004Congenital atresia of pulmonary valve
13213009Congenital heart disease
204354004Congenital tricuspid atresia and stenosis
62067003Hypoplastic left heart syndrome
204456001Subdiaphragmatic total anomalous pulmonary venous return
204457005Supradiaphragmatic total anomalous pulmonary venous return
86299006Tetralogy of Fallot
204297006Total great vessel transposition
UMLS CUI:4C0039685 C0040761 C0041207 C0152021 C0152101 C0158616 C0242855 C0265917 C0265921
ICD-9-CM Code:5
746.01Atresia of pulmonary valve, congenital
745.0Common truncus
745.10Complete transposition of great vessels
746.7Hypoplastic left heart syndrome
745.2Tetralogy of fallot
747.41Total anomalous pulmonary venous connection
746.1Tricuspid atresia and stenosis, congenital
ICD-10-CM Code:6
Q20.0Common arterial trunk
Q22.4Congenital tricuspid stenosis
Q20.3Discordant ventriculoarterial connection
Q23.4Hypoplastic left heart syndrome
Q22.0Pulmonary valve atresia
Q21.3Tetralogy of Fallot
Q26.2Total anomalous pulmonary venous connection

Affected Protein Names and Codes

Enzyme Commission Number:7
N/A
UniProt Number:8
N/A
Affected Protein:9 N/A

Analytes or Measurements

These measurements are associated with the condition:

LOINC Long Common Name10 Analyte
Short Name11
LOINC
Number12
Units13
CCHD newborn screening interpretation   73700-7 Answer list
CCHD newborn screening protocol used [Type] CCHD protocol 73697-5  
Oxygen saturation.preductal-oxygen saturation.postductal [Mass fraction difference] in Bld.preductal and Bld.postductal Pre-post difference 73696-7 %
Oxygen saturation in Blood Postductal by Pulse oximetry Postductal O2 sat 59418-4 %
Oxygen saturation in Blood Preductal by Pulse oximetry Preductal O2 sat 59407-7 %

More Information

Additional information is available from the Online Mendelian Inheritance in Man (OMIM®)14:

Table — Code mapping table for representative CCHD conditions across standard terminologies.

Condition CDC/BPA code15 ICD-9-CM code5 ICD-10-CM code6 SNOMED CT code3 STS/IPCCC code16
Hypoplastic Left Heart Syndrome 746.70 746.7 Q23.4 62067003 730
Pulmonary Atresia 746.00 746.01 Q22.0 204342004 330
Truncus Arteriosus 745.00 745.0 Q20.0 61959006 160
Total Anomalous Pulmonary Venous Connection (TAPVC/TAPVR) 747.42 747.41 Q26.2 111323005 200
d-Transposition of the Great Arteries 745.10 745.10 Q20.3 26146002, 204297006 880
Tetralogy of Fallot 745.2 745.2 Q21.3 86299006 290
Tricuspid Atresia 746.100 746.1 Q22.4 204354004 390

Legend

1

Condition Name and Abbreviation — curated by the NLM and selected from among the names used by the Advisory Committee on Heritable Disorders in Newborns and Children (Committee), National Newborn Screening Information System (NNSIS), the American College of Medical Genetics (ACMG), the HHS Office of the National Coordinator for Health Information Technology (ONC)/American Health Information Community (AHIC) Personalized Health Care Work Group, and input from the newborn screening community.

2

Category — based on the U.S. Department of Health and Human Services (HHS) Recommended Uniform Screening Panel. Conditions designated as "core" should be included in every newborn screening program, and "secondary" conditions are some of the disorders that may be detected during screening for a core disorder. Conditions classified as "other" are those that are screened for by some states but are not part of the Recommended Uniform Screening Panel.

3

SNOMED CT® CodeSystematized Nomenclature of Medicine — Clinical Terms code is assigned by the International Health Terminology Standards Development Organisation (IHTSDO). SNOMED CT is a concept-oriented clinical terminology that has been designated as a U.S. standard for electronic health information exchange. The Newborn Screening Coding and Terminology Guide uses some codes from the US Extension to SNOMED CT.

4

UMLS CUI — a concept unique identifier (CUI) assigned to every concept in the Unified Medical Language System (UMLS®).

5

ICD-9-CM CodeInternational Classification of Diseases, Ninth Revision, Clinical Modification code is assigned to diagnoses associated with hospital utilization in the U.S. It is a current US standard for use in administrative healthcare transactions. Although ICD-9-CM codes are fairly specific, in certain cases, the same ICD-9-CM code might apply to several disorders in the same group (e.g. amino acid disorders).

6

ICD-10-CM CodeInternational Classification of Diseases, Tenth Revision, Clinical Modification code. Although ICD-10-CM codes are fairly specific, in certain cases, the same ICD-10-CM code might apply to multiple related disorders.

7

Enzyme Commission (EC) Number — a unique identifier for the affected enzyme (if the affected protein is an enzyme); the EC number is assigned by the Recommendations of the Nomenclature Committee of the International Union of Biochemistry and Molecular Biology on the Nomenclature and Classification of Enzymes by the Reactions they CatalyseExternal Web Site Policy.

8

UniProt Number — a unique identifier assigned to all proteins, including enzymes, hemoglobin subunits, and immunoglobulin chains. The UniProt database is maintained by the Universal Protein ResourceExternal Web Site Policy, an international collaboration.

9

Affected Protein — the structure that is abnormal in this condition. The affected protein could be an enzyme, a hormone, or a specific molecule such as hemoglobin or immunoglobulin chain. If the affected protein is an enzyme, it will have an Enzyme Commission (EC) number.

10

LOINC Long Common Name — derived by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee from the measurement's formal name by using conventional names for analytes and procedures. The long common name eliminates the parts of the formal name that are not needed to distinguish the test from related tests.

11

Analyte Short Name — an abbreviation for the analyte.

12

LOINC Number — the unique and permanent code assigned by the Logical Observation Identifiers Names and CodesExternal Web Site Policy (LOINC®) Committee to identify the test measurement. LOINC codes are unique for different test methods and different units of reporting to enable interoperability and comparison of results from different labs. LOINC is a U.S. government standard for electronic health information exchange of laboratory tests and other measurements in Interoperability Specifications produced by the Healthcare Information Technology Standards Panel (HITSP).

13

Units — what is being counted or measured, using the Unified Code for Units of MeasureExternal Web Site Policy (UCUM). Ratios whose units fully cancel each other are indicated by {Ratio}. UCUM is the US standard for reporting units in laboratory messages. Results that are not quantitative have either a link to the specific LOINC answer list for that analyte or appropriate text (such as "Pos or Neg" or "Specific alleles").

14

OMIMOnline Mendelian Inheritance in Man®External Web Site Policy is a comprehensive resource about human genes and genetic diseases. It focuses primarily on the relationship between genotype and phenotype. It is currently maintained by Johns Hopkins University.

15

CDC/BPA — The Centers for Disease Control and Prevention/ British Paediatric Association (CDC/BPA) codes are unique codes developed by the CDC for tracking birth defects. The codes stem from ICD-9-CM with modifications based on BPA terminology.

16

STS/IPCCC — The Society of Thoracic Surgeons' (STS) codes and International Pediatric and Congenital Cardiac Codes (IPCCC) are specific codes for cardiac lesions. IPCCC uses detailed, multi-axial coding to capture the full details of the lesion. IPCCC codes are encouraged for use in cardiac research by the National Heart, Lung, and Blood Institute. STS codes are more general codes that were based on the fine-grained IPCCC codes. STS codes are used to record patient diagnoses in the STS Congenital Heart Surgery Database.

Record created: April 30, 2013
Record last updated: November 2, 2015